← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Personalized Medicine in Psychiatry (ISSN 2468-1725, 2468-1717) is a journal published by Elsevier in the United States. It covers Medicine, Psychology, Clinical Psychology and Psychiatry and Mental Health. It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 2.1, Scopus Q3, Web of Science Q3, CiteScore 1.8 and HEC X-Category. Article processing charge: USD 2,790. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Personalized Medicine in Psychiatry

ISSN
2468-1725, 2468-1717
Subject area
MedicinePsychologyClinical PsychologyPsychiatry and Mental HealthNeurology (clinical)
Indexed
ScopusWeb of SciencePubMedHEC
Scopus Quartile
Q3
WoS Quartile
Q3
Impact Factor
2.1
Country
United States
Publisher
Elsevier
SJR
0.58
Open access
No
APC (USD)
2790
About the journal
Personalized Medicine in Psychiatry provides a home for basic and clinical investigators, neuroscientists, psychiatrists, psychologists, residents, and medical and graduate students to publish high quality research papers, reviews, new ideas and perspectives, debates, case reports, applied technologies that contribute towards advancing our basic, clinical and therapeutic knowledge of personalized medicine in psychiatry. Personalized medicine in psychiatry seeks to identify factors that contribute to vulnerability to psychiatric disorders and accuracy of diagnosis as well as the major goal of increasing efficacy of therapeutic interventions and decreasing adverse effects by considering the individual characteristics of each patient (e.g. genetics and epigenetics, physiological, endocrinological, psychological, brain imaging and medical comorbidity). Personalized medicine in psychiatry encompasses both which individual should receive what specific type of treatment based on personalized measures, and also identifies those at risk, thereby reducing long-term costs of mental health as well as morbidity. The journal fills a broad void encompassing studies of endophenotypes and biological markers, pharmacological and psychotherapeutic approaches, educational and rehabilitation concerns, and environmental and behavioral, psychological and social research, all with the aim of moving toward the search for individualized treatments tailored for each patient. Most importantly, its goal is to identify predictors of response in individual patients. Topics include, but are not limited to: Personalized Medicine Psychiatric Disorders Psychopharmacology Psychotherapy Genetics Epigenetics Metabolomics Proteomics Transcriptomics Psychophysiology Neuropsychology Structural and functional brain imaging Prevention Psychopathology Mood disorders including depression and bipolar disorder Alzheimer's disease Anxiety disorders Psychotic disorders Endophennotypes Post mortem brain studies Personality disorders TMS DBS ECT
Aims and Scope
Personalized Medicine in Psychiatry provides a home for basic and clinical investigators, neuroscientists, psychiatrists, psychologists, residents, and medical and graduate students to publish high quality research papers, reviews, new ideas and perspectives, debates, case reports, applied technologies that contribute towards advancing our basic, clinical and therapeutic knowledge of personalized medicine in psychiatry. Personalized medicine in psychiatry seeks to identify factors that contribute to vulnerability to psychiatric disorders and accuracy of diagnosis as well as the major goal of increasing efficacy of therapeutic interventions and decreasing adverse effects by considering the individual characteristics of each patient (e.g. genetics and epigenetics, physiological, endocrinological, psychological, brain imaging and medical comorbidity). Personalized medicine in psychiatry encompasses both which individual should receive what specific type of treatment based on personalized measures, and also identifies those at risk, thereby reducing long-term costs of mental health as well as morbidity. The journal fills a broad void encompassing studies of endophenotypes and biological markers, pharmacological and psychotherapeutic approaches, educational and rehabilitation concerns, and environmental and behavioral, psychological and social research, all with the aim of moving toward the search for individualized treatments tailored for each patient. Most importantly, its goal is to identify predictors of response in individual patients. Topics include, but are not limited to: Personalized Medicine Psychiatric Disorders Psychopharmacology Psychotherapy Genetics Epigenetics Metabolomics Proteomics Transcriptomics Psychophysiology Neuropsychology Structural and functional brain imaging Prevention Psychopathology Mood disorders including depression and bipolar disorder Alzheimer's disease Anxiety disorders Psychotic disorders Endophennotypes Post mortem brain studies Personality disorders TMS DBS ECT
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
Journal's Author Direct Link ↗
Scopus URL
Scopus Direct Link ↗
APC Information URL
APC Information Direct Link ↗
WoS URL
Web of Science Direct Link ↗
SCImago Ranking
10220
HEC
X-Category
Registered In
2017
Average Time To Publication After Submission (In Weeks)
—
Waiver policy
—
Scopus Cite Score
1.8
WoS Status
Emerging Sources Citation Index (ESCI)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Personalized Medicine in Psychiatry

Is Personalized Medicine in Psychiatry HEC recognised?

Yes. The catalogue records Personalized Medicine in Psychiatry in HEC category X of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Personalized Medicine in Psychiatry indexed in Scopus?

Yes. Personalized Medicine in Psychiatry is listed as Scopus-indexed, in quartile Q3, with a CiteScore of 1.8. Check its current status on the Scopus Sources page.

Is Personalized Medicine in Psychiatry in Web of Science?

Yes. Personalized Medicine in Psychiatry is listed as a Web of Science journal in the Emerging Sources Citation Index (ESCI), with Web of Science quartile Q3. Confirm on Clarivate's Master Journal List.

What is the impact factor of Personalized Medicine in Psychiatry?

The recorded journal impact factor of Personalized Medicine in Psychiatry is 2.1. Clarivate updates impact factors every year in Journal Citation Reports.

Is Personalized Medicine in Psychiatry open access, and what does it charge?

Personalized Medicine in Psychiatry is not recorded as fully open access and its APC is USD 2,790. Fees change, so check the journal's website before you submit.

Who publishes Personalized Medicine in Psychiatry?

Personalized Medicine in Psychiatry is published by Elsevier in United States, under ISSN 2468-1725 and 2468-1717.

Research profile

Main research topics: Treatment of Major Depression, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Schizophrenia research and treatment, Electroconvulsive Therapy Studies, COVID-19 and Mental Health, Transcranial Magnetic Stimulation Studies.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal